Therapy with interferon in HIV-infected patients with chronic viral hepatitis
Soriano, V.; García-Samaniego, J.
Revista Clinica Espanola 194(10): 887-889
1994
ISSN/ISBN: 0014-2565 PMID: 7528439 Document Number: 438433
Document emailed within 1 workday
Related Documents
Nakamura, H.; Ogawa, H.; Kuroda, T.; Yamamoto, M.; Enomoto, H.; Kishima, Y.; Yoshida, K.; Ito, H.; Matsuda, M.; Noguchi, S. 2002: Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus Hepato-Gastroenterology 49(47): 1373-1376Kokoreva, L.N.; Zmyzgova, A.V.; Shalygina, N.B. 1996: The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results Terapevticheskii Arkhiv 68(2): 10-14
Alscher, D.M.; Bode, J.C. 1992: Therapy of acute and chronic viral hepatitis C (non-A, non-B) with interferon-alpha Medizinische Klinik 87(10): 532-539
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Pastore, G.; Santantonio, T.; Monno, L.; Milella, M.; Luchena, N.; Angarano, G. 1988: Permanent inhibition of viral replication induced by low dosage of human leukocyte interferon in patients with chronic hepatitis B Hepato-Gastroenterology 35(2): 57-61
Zielińska, W.; Korczak-Rogoń, A.; Paszkiewicz, J.; Kowalik, M.; Cummins, J.M.; Georgiades, J.A. 1996: Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients Archivum Immunologiae et Therapiae Experimentalis 44(5-6): 359-366
Rao, H-ying.; Wei, L.; Li, J.; Zhang, L-fang.; Chen, H-yong.; Zhu, L-min.; Liu, F.; Sun, Y.; Wang, H. 2009: Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response Hepato-Gastroenterology 56(90): 328-334
Su, S-Yung. 2019: The impact of national viral hepatitis therapy program and hepatitis B vaccination program on mortality from acute and chronic viral hepatitis in Taiwan Hepatology International 13(2): 157-164
Hobstová, J.; Vitous, A. 2011: Viral hepatitis at the beginning of the 21st century--value of liver biopsy in the context of development of new non-invasive diagnostic methods and in relation to the modern therapy of chronic viral hepatitis Ceskoslovenska Patologie 47(2): 44-49
Niederau, C.; Heintges, T.; Niederau, M.; Stremmel, W.; Strohmeyer, G. 1993: Selection of patients with chronic hepatitis B for therapy with alpha-interferon Zeitschrift für Arztliche Fortbildung 87(4): 273-278
Wright, H.I. 1990: Interferon treatment of chronic viral hepatitis G.E.N 44(1): 71-77
Pirovino, M. 1992: Interferon treatment of chronic viral hepatitis Therapeutische Umschau. Revue Therapeutique 49(5): 302-309
Nakamura, H.; Uyama, H.; Enomoto, H.; Kishima, Y.; Yamamoto, M.; Yoshida, K.; Okuda, Y.; Hirotani, T.; Kuroda, T.; Ito, H.; Matsuda, M.; Terabayashi, M.; Noguchi, S. 2003: The combination therapy of interferon and amantadine hydrochloride for patients with chronic hepatitis C Hepato-Gastroenterology 50(49): 222-226
Sajjad, S.F.; Ahmed, W.u.; Arif, A.; Alam, S.E.; Waquar, J. 2012: Weight loss with interferon and ribavirin therapy in chronic hepatitis C patients JPMA. Journal of the Pakistan Medical Association 62(11): 1229-1232
Besirbellioglu, B.; Gul, C.; Gorenek, L.; Eyigun, C.P.; Hacibektasoglu, A.; Van Thiel, D.H. 1999: Interferon therapy of Turkish patients with chronic hepatitis B virus infection Hepato-Gastroenterology 46(25): 387-390
Abe, Y.; Ueda, T.; Kato, T.; Kohli, Y. 1994: Effectiveness of interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 52(7): 1817-1822
Derbala, M.F.; Amer, A.M.; El Defrawi, I.E. 2006: Anti-HCV IgM as predictor of response to interferon therapy in schistosomal patients with chronic hepatitis C Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 25(1): 44
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528
Beker, S.; Pujol, F.H.; Beker, B. 1995: Is the treatment of chronic viral hepatitis C with interferon-alpha effective? G.E.N 49(2): 165-169
Stancek, D.; Fuchsberger, N.; Borecký, L.; Kotuliaková, M.; Hrúzik, J.; Sylvanová, E.; Sudová, J. 1988: Human interferon alfa therapy and hepatitis B virus markers in the serum of patients with chronic course of illness Acta Virologica 32(2): 148-152